文献速递牙体牙髓病儿童口腔

支架与再生材料用于治疗伴有根尖周病变的年轻恒牙坏死牙髓:伞状综述

Use of scaffolds and regenerative materials for the treatment of immature necrotic permanent teeth with periapical lesion: Umbrella review.
PubMed 文献 · Int Endod J · 2022-07-25

本伞状综述评估支架与再生材料治疗伴有根尖周病变的年轻恒牙坏死牙髓的成功率,指标包括根尖闭合、牙根长度增加、根管壁增宽、组织活力和根尖周病变修复。检索Medline、ISI Web of Science和Scopus后最终纳入6篇系统综述,最常见支架为血凝块,最常见再生材料为MTA,其次为Biodentine;所有纳入研究均报告牙根长度增加和根管壁增宽,但仅1篇偏倚风险低。

要点

  • 血凝块是治疗年轻恒牙坏死牙髓时最常用的支架。
  • MTA和Biodentine在分析结果中未显示差异。
  • 牙根长度增加和根管壁增宽是最常用的成功指标。

核心结论

  • 血凝块是诱导年轻恒牙坏死牙髓再生治疗中最常用的支架。
  • 牙根长度增加和根管壁增宽是研究中常用的成功指标。
  • MTA与Biodentine在分析结果中未显示差异。
  • 质量评估和偏倚风险评估显示需要设计方法学更严谨的研究,以推荐可信且可预测的治疗方案。

研究设计与样本

  • 伞状综述,检索Medline、ISI Web of Science和Scopus数据库。
  • 去重后找到155篇文章,排除133篇非相关和15篇不符合排除标准,方法学质量评估后再排除1篇,最终纳入6篇系统综述。
  • 使用AMSTAR-2工具评估方法学质量,使用ROBIS工具评估偏倚风险。
  • PROSPERO注册号CRD42021248404。

主要发现

  • 最常用的支架是血凝块,其他包括聚乳酸-羟基乙酸共聚物和富血小板纤维蛋白基质。
  • 最常用的再生材料是MTA,其次是Biodentine。
  • 所有纳入研究均报告牙根长度增加和根管壁增宽,比例不同,并报告根尖周病变修复。
  • ROBIS分析显示仅1篇文章偏倚风险低,2篇偏倚风险不明确,其余3篇偏倚风险高。

关键数值与推荐

  • 血凝块是最常用的支架,因其最易放置于根管内且无需从患者抽取血液。
  • MTA和Biodentine作为封闭材料与根管壁增厚、根尖闭合及根尖周炎症状体征减轻相关。
  • 多数纳入综述评估的是病例报告,仅少数包含临床试验。
  • 多数综述缺乏偏倚风险分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数纳入综述评估的是病例报告,仅少数包含临床试验。
  • 多数综述缺乏偏倚风险分析。
  • 质量评估和偏倚风险评估显示需要设计方法学更严谨的研究,以推荐可信且可预测的治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current treatment of immature necrotic permanent teeth with a periapical lesion is regenerative endodontics, which is based on tissue engineering under the triade of stem cells, scaffolds and bioactive molecules. OBJECTIVES: This Umbrella Review was aimed to evaluate the success of scaffold and regenerative materials used for the treatment of these teeth, in terms of apical closure, tooth length increase, widening of root canal walls, tissue vitality and periapical lesion repair. METHODS: An extensive literature research was carried out in the Medline, ISI Web of Science, and Scopus databases for relevant systematic reviews matching the keyword search strategy. Based on inclusion and exclusion criteria, reviewers independently rated the quality of each study to determine their level of evidence. Methodological quality assessment of each article was obtained using A Measurement Tool to Assess Systematic Reviews (AMSTAR)-2 tool, and risk of bias was assessed with the Risk of Bias in Systematic Reviews (ROBIS) tool. RESULTS: After removing duplicates, 155 articles were found; from which 133 were excluded for being non-relevant and 15 other due to exclusion criteria. One more was discarded after methodological quality evaluation, for a total of six articles remaining. The most common scaffold used was the blood clot, others used were poly lactic-co-glycolic acid and platelet-rich fibrin matrix. The most common regeneration material used was Mineral Trioxide Aggregate (MTA), followed by Biodentine. An increase in tooth length and widening of root canal walls were reported in all selected studies with different proportions, as well as periapical lesion repair. ROBIS analysis showed that only one article had low bias, two were classified as unclear bias, while the remaining three had high risk of bias. DISCUSSION: An exhaustive literature search was carried out applying language filters, high-quality indexed journals, year of publication, which ensures the best quality articles were included. Blood clot was the most used scaffold as is the most easy to place inside the canal and does not require to extract blood from the patient. The use of MTA and Biodentine as sealing materials has been associated with thickening of canal walls, apical closure and reduced signs and symptoms of apical periodontitis. However, most of the included reviews assessed were case reports and only in a few of them were clinical trials included. There is also a lack of risk of bias analysis in most reviews. CONCLUSION: The blood clot is the most common scaffold used for inducing regeneration during the treatment of immature necrotic teeth. Tooth length increase and widening of root canal walls are the most common criteria used in the studies as success indicators. MTA and Biodentine did not show differences in the results analysed. Quality assessment and bias risk evaluation showed that it is necessary to design better studies with rigorous methodology to recommend a trustable and predictable protocol for the treatment of immature necrotic permanent teeth with periapical lesions. REGISTRATION: International Prospective Register of Systematic Reviews (PROSPERO) CRD42021248404.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Caviedes-Bucheli J, Muñoz-Alvear HD, Lopez-Moncayo LF, et al. Use of scaffolds and regenerative materials for the treatment of immature necrotic permanent teeth with periapical lesion: Umbrella review. Int Endod J. 2022. PMID: 35821587. doi:10.1111/iej.13799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。